알림

알림 Pro 차트

Allarity Therapeutics Inc... (ALLR)

NasdaqCM: ALLR · 실시간 가격 · USD

1.36

-0.04 (-2.86%)

종가 기준: Aug 13, 2026, 3:59 PM

1.37

+0.72%

애프터마켓: 7:39 PM

-2.86% (1D)

매수호가	1.02
시가총액	21.64M
매출 (ttm)	345K
순이익 (ttm)	-11.25M
베타	0.51
EPS (ttm)	-0.7
P/E (ttm)	n/a
선행 P/E	-1.4
P/B (ttm)	3.11
P/S (ttm)	62.72
Earnings Date	n/a

매도호가	1.83
거래량	150,744
평균 거래량 (20일)	151,756
시가	1.42
전일 종가	1.40
일중 범위	1.25 - 1.43
52주 범위	0.77 - 2.35
애널리스트	n/a
목표주가	10.25 (653.68%)
배당	n/a
배당락일	n/a

ALLR 소개

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of po...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Dec 21, 2021

직원 수 7

상장 거래소 NasdaqCM

티커 ALLR

웹사이트 https://www.allarity.com

전체 기업 정보

재무 실적

2025년 Allarity Therapeutics의 매출은 320K로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -11.23M로, -54.19% 감소했습니다.

재무제표

애널리스트 전망

애널리스트 1명의 투자의견을 종합하면 ALLR 주식의 평균 등급은 "null"입니다. 12개월 목표주가는 10.25로, 최근 주가 대비 653.68% 상승 여력입니다.

주가 전망

어닝 서프라이즈

Allarity Therapeutics가 May 15, 2026에 분기 실적을 발표했습니다:

매출 $25K 예상치 하회 $0, 및 Infinity% 전년 대비 성장.

EPS -0.17 예상치 상회 0.05, 및 90.29% 전년 대비 성장.

뉴스

3주 전 · Zacks

Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?

Here is how Allarity Therapeutics, Inc. (ALLR) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.

1개월 전 · Zacks

Is Allarity Therapeutics, Inc. (ALLR) Stock Outpacing Its Medical Peers This Year?

Here is how Allarity Therapeutics, Inc. (ALLR) and Amgen (AMGN) have performed compared to their sector so far this year.

1개월 전 · Zacks

Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year?

Here is how Allarity Therapeutics, Inc. (ALLR) and Alterity Therapeutics Limited - Sponsored ADR (ATHE) have performed compared to their sector so far this year.

2개월 전 · Zacks

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Here is how Bioventus (BVS) and Allarity Therapeutics, Inc. (ALLR) have performed compared to their sector so far this year.

5개월 전 · TipRanks

Allarity closes $20M financing for stenoparib advancement

Allarity (ALLR) Therapeutics closed a $20 million non-convertible debt financing with Streeterville Capital. The transaction is structured as a note purchase agreement pursuant to which the Company is...

2 페이지 중 1

Allarity Therapeutics Inc... (ALLR)